cover how ethnicity may affect the management of pain. The areas to be considered are: 1. Definition of ethnic groups. 2. Intensity of pain experienced by the patient. There may be a physiological difference in pain threshold for a given noxious stimulus, or the patient may have different perceptions of similar afferent noxious signals. 3. Expression of pain by the patient. Differences in the attitudes of patients to the investigator or healthcare staff responsible for administering pain relief may cause the same degree of pain to be communicated differently. There may also be differences in the reliability of methods to evaluate pain. 4. Relationship of healthcare staff to patient. Ethnic differences may influence the treatment plan prescribed by the medical and nursing staff. 5. Response to drug treatment. There may be pharmacogenetic differences in drug disposition or the response to analgesic and adverse effects. Ethnic factors may also affect the desired endpoint for treatment. The purpose of this review is to summarize the key findings from this area of research in Asians and outline the difficulties in examining this question.
DEFINITION OF ASIANS AND CAUCASIANS
Unfortunately, the term "Asian" is broad and masks important variations in country of origin, language and other factors related to health 15 . In the United Kingdom, Asian usually refers to migrants from Pakistan and India, while in Australasia, Asian usually refers to people from Southeast Asia. The Asian groups in this review have included Chinese 6, 7, 9, 16, 17 or Nepalese 6, 7, 16, 17 residents in Hong Kong, Chinese 3, 4, 18, 19 , Japanese 3, 4, 19 or Filipino 4,19 residents in the United States and non-English speaking Pakistani and Indian migrants in the United Kingdom 5 . Three studies inadequately described their Asian groups 8, 10, 20 .
Caucasian groups are usually not well defined. They included Europeans 6, 7, 16, 17 residing in Hong Kong, English-speaking Caucasians in the United Kingdom 5 , Europeans residing in the United States 19 or Caucasians 4 and white Americans 3, 8, 10, 18, 19 .
These examples illustrate the heterogeneity across the Asian and Caucasian groups, which limits the generalizability of the results. This problem may be improved by collecting a range of information that will accurately describe ethnicity, race and culture 21 . Guidelines have recently been put forward by the British Medical Journal 22 . Measures of ethnicity may include a range of factors such as country of birth, language spoken at home, period of residence, socioeconomic class, education and ancestry. Most of these factors should be included in future studies to reduce any misclassification bias.
INTENSITY OF PAIN
A recent review of studies on cultural differences in responses to laboratory-induced pain concluded that there appeared to be no ethnic differences in the neurophysiological detection of pain; that is, pain threshold 23 . In the clinical setting, there was no significant difference in the mean pain score between Asians (Chinese, Japanese, Southeastern Asians and Filipinos) and Europeans after controlling for the difficulty of third molar extraction, sex, age, education level and the number of generations 19 .
However it was suggested that age, sex, investigators' ethnicity and the subjects' social conditions may have confounded the response to painful stimuli in the laboratory setting 23 . This may explain why Woodrow and co-workers 3 showed that Chinese and Japanese had lower pain tolerance than Caucasians as determined by mechanical pressure on the Achilles tendon. In another study, Asians were found to have higher pain scores and lower ratings of their own ability to cope after ear piercing than Caucasians 20 .
Ethnicity is not the only factor that may influence pain intensity and there is much individual variation as a result of other differences in attitudes, beliefs, degree of adaptation to health systems, and emotional and psychological states [24] [25] [26] . It has also been difficult to separate any differences in the individual perception of pain from biases that may occur in the expression of pain.
EXPRESSION OF PAIN
A stoical attitude towards coping with pain may explain why some Asians are likely to demand less opioid or cease its use prematurely when there is some pain relief 16 . The Chinese think that "Western" drugs work promptly, are strong and efficacious, but have high risk of side-effects 27 and thus they may not wish to use them for longer than it is absolutely necessary. Despite these perceptions, inadequate education of patients in what to expect with pain and analgesia may also contribute to poor postoperative pain relief 28 . This problem may be more prevalent in Asian patients because they are more passive than Caucasians in their relationship with health professionals. Asian patients will rarely admit ignorance or ask questions about their treatment 27 .
In recent studies, many researchers have used the visual analogue scale (VAS) for subjective pain measurement 6, 7, 9, 10 . The linear analogue scale can be used in Chinese patients with relative accuracy provided it has been well explained by health professionals 29 . The error from employing a vertical presentation of the scale was less than that from a horizontal one 29 , perhaps reflecting the difference in how traditional Chinese text is displayed.
RELATIONSHIP OF HEALTHCARE STAFF TO PATIENT
If patients do not express their pain, verbally or nonverbally, they rely upon others such as nurses to recognize their pain and to give them analgesia 30 . Commonly used strategies in the postoperative pain assessment include: (1) how the patient looks, (2) what the patient says, (3) the patient's manner of talking and (4) nurses' and physicians' past experience of similar circumstances 31 . Problems may occur even without considering ethnic influences. Some nurses lacked the ability to assess pain through nonverbal cues 32 . Both nurses and physicians can overestimate low and underestimate high levels of pain as indicated by their patients 31 . Several studies suggested that clinicians and nurses inadequately prescribe and administer sufficient doses of opioid, with little attention to patient responses 28, 30, 33 . Inadequate analgesia is caused by the reluctance of clinicians and nurses to administer sufficient doses of opioid because of an exaggerated fear of opioid addiction 34 .
However, a recent study suggested that the patient's ethnicity has a greater impact on the amount of opioid prescribed by the clinician than on the amount of opioid self-administered by the patient 10 . Health professionals need to communicate with the patient about pain management 10 , be aware of the cultural differences and the role of cultural factors in influencing the behaviour of people in pain 26 . This in turn will affect the pain assessment and intervention given to patients by their healthcare providers.
RESPONSE TO DRUG TREATMENT Pharmacogenetics
Pharmacogenetics deals with clinically significant hereditary variation in the response to drugs as a result of altered drug disposition and abnormal drug reactions in affected persons 35 . The term polymorphism is usually applied when the frequency of both phenotypes is greater than 1% 35 . For example, the absence and presence of cytochrome P450 enzymes CYP2D6 in subjects are referred to as "poor metabolizer" and "extensive metabolizer" respec-tively. Ethnic differences in drug metabolism have been the subject of a recent review 36 . The prevalence of poor metabolizers is greater in Caucasian populations (5% to 10%) than in Japanese and Chinese (0% to 0.7%) 36 . Pharmacogenetics may play an important role in explaining the wide variability of the clinical response to many opioid drugs 37 . Several studies suggest that there may be variations in the rate and pattern of opioid metabolism between Asians and Caucasians.
Pharmacokinetic differences
Codeine is metabolized mainly by conjugation with glucuronic acid, but also by N-demethylation, and O-demethylation which depends on CYP2D6 38 . In a randomized, double-blind, three-way cross-over study with a single oral dose of codeine against morphine and placebo, poor metabolizers and extensive metabolizers had equal amounts of plasma morphine and morphine-6-glucuronide after the administration of morphine 38 . However, morphine and morphine-6glucuronide could not be detected in 13 of the 14 poor metabolizers after codeine administration 38 . The study also showed that there was a significant reduction in pain severity (using a visual analogue scale) from different types of experimental pain stimuli in subjects taking morphine, but there was no effect with codeine in poor metabolizers 38 . This supported the theory that the analgesic effect of codeine depends on its O-demethylation 38 . It is important to note that this study did not directly address the issue of ethnic differences, but the results would imply that codeine is more likely to be metabolized adequately in Asian patients.
However, Yue and co-workers showed that Swedish Caucasians excreted significantly greater proportions of codeine-6-glucuronide (62%) than Chinese volunteers (44%) after a single oral dose of codeine 39 . They also showed that the excretion of unchanged drug was higher in the Chinese group (7%) than in the Caucasians (4%) 39 . These results suggested that Chinese were less able to metabolize codeine by glucuronidation, which may partly be responsible for the smaller recommended dose in the treatment of pain in Chinese patients 36 .
In contrast, Zhou and co-workers 18 showed that the rate of clearance of morphine was higher in Chinese subjects than in Caucasian subjects when given the same doses of morphine. Also, the partial metabolic clearance of morphine to morphine-3-glucuronide and morphine-6-glucuronide was significantly higher in Chinese than Caucasian subjects 18 . The results from Zhou 18 and Yue 39 illustrate that glucuronidation rates can differ between different types of opioid in Caucasian and Chinese populations. However, the rate of glucuronidation can also be influenced by gender, smoking and food substances that inhibit glucuronidation 39 .
The pharmacokinetic profile of pethidine has been examined 17, 40 . In one study, Chinese and Nepalese appeared to eliminate a single dose of intramuscular pethidine more slowly than Caucasians 17 . If multiple doses of pethidine are prescribed in Chinese and Nepalese patients there may be accumulation of pethidine and norpethidine 17 . However, in a latter trial by Houghton 40 , there was no evidence of genetic polymorphism in the hydrolysis or oxidative demethylation of pethidine in Caucasians or in Chinese and Nepalese patients.
In contrast to pethidine, the same authors showed that the elimination half-life of alfentanil in Chinese and Nepalese was shorter than that of Caucasians 16 . However, the pharmacokinetic part of this study was limited by very small groups of four or five patients and short sampling times.
Although there may be ethnic differences in the pharmacokinetics of opioids, the results are conflicting and have not been demonstrated to have any clinical significance. In general, most pharmacokinetic studies have been performed on a single homogeneous population and based on these findings, dosage recommendations have been extrapolated to populations throughout the world 18 . Pharmacokinetic studies are usually conducted with small sample sizes and a limited choice of study subjects (often healthy male subjects). In response to addressing the ethnic factors influencing drug safety and efficacy, drug regulators in Japan, United States and Europe have recently liberalized regulations to increase the acceptability of foreign data in support of pharmaceutical drug approvals 41 .
Pharmacodynamic differences
There are no studies that have determined whether or not there are ethnic differences in opioid response at equivalent effect site concentrations of opioids. The interpretation of differences in opioid usage is complicated by potential differences in both the analgesic response and the side-effects that may limit the amount of opioid used. In addition there may be nonpharmacological ethnic differences in the way patients perceive, evaluate and titrate their analgesia and side-effects.
Studies of opioid analgesia in Asians and Caucasians during the perioperative period are shown in Table 1 . All studies in Table 1 , except Aun's study 16 , were related to postoperative analgesia. Of 668 A. LEE, T. GIN, T. E. OH Anaesthesia and Intensive Care, Vol. 25, No. 6, December 1997 the eight studies in Table 1 , three showed no significant difference between Asians and Caucasians in the opioid dose used. In one of these, there was no difference in the amount of self-administered opioid but the trend was for lower doses in Asians than in Caucasians (Asians: 2.01 mg/h versus Caucasians: 2.79 mg/h) 10 .
Experimentally, Caucasians had greater depression in ventilation and reduction in blood pressure than Asians when morphine was given 18 . These results suggested that Caucasians were more responsive to morphine than Chinese patients 36 . Clinically, there were no differences between Asians and Caucasians in the postoperative respiratory function when pethidine was used 6 , but these results would have been heavily influenced by the normal reduction in respiratory function seen after upper abdominal surgery. In a subset of Asian female patients, postoperative recovery after intraoperative alfentanil was said to be slightly slower than in Caucasians 16 but this may have reflected other differences in surgery and anaesthetic technique which were not controlled for. For example, the mean duration of an alfentanil infusion was ten minutes longer in the Asian females.
Asians were more sedated than Caucasians in the first four hours after upper abdominal surgery when using patient-controlled analgesia (PCA) pethidine, even though they had a lower pethidine consumption 6 . The incidence of nausea and vomiting associated with morphine was significantly higher in Asians than Caucasians 18 . Differences in side-effects may thus influence the amount of opioid used. For example, Asians who were more sedated from opioid may not make as many PCA demands, or may demand less doses of opioid from healthcare staff, especially if there are also language difficulties.
Unfortunately, there are significant limitations in study design for most of the clinical studies in Table 1 . Sample sizes were very unbalanced, depending on the country in which the study was performed. Three of the studies had greater than ten times the number of patients in one group than the other 8-10 and three studies had less than ten patients in one group [6] [7] [8] . Different opioids were used and some studies used different opioids and then calculated equianalgesic doses for comparisons. An equianalgesic dose was defined as equivalents of an opioid (for example, morphine) using standardized algorithms which took into account differences in the opioid (morphine) equivalents between oral and parenteral preparations 10 . The types and route of opioid administration included intraoperative intravenous alfentanil 16 , equianalgesic doses comparable to intramuscular morphine 8 , equianalgesic doses comparable to parental pethidine 4 , intramuscular papaveretum 5 and patient-controlled analgesia pethidine 6 , morphine 9,10 or nalbuphine 7 . Data collection of the total postoperative opioid dosage included both retrospective 4,8,10 and prospective [5] [6] [7] 9, 16 drug chart reviews. The period of postoperative pain management varied between studies from twenty-four hours 6 to hospital discharge 8 .
Although these studies provided information on opioid usage they could not determine exactly why any differences had occurred. The large individual variability in opioid usage and the small sample sizes could have hidden true ethnic differences in analgesic response, side-effect profile and opioid consumption. As outlined above, differences may also have occurred as a result of the patient's interaction with a monoculturally-based healthcare system.
In recent studies, many researchers have used the PCA technique in opioid administration 6, 7, 9, 10 . Although the use of PCA will remove some of the healthcare provider's biases, the appropriate use of the technique depends on effective patient education. Variations in PCA dosage may still be a result of differences in attitudes towards pain management or real differences in opioid pharmacology. Health professionals should be conscious of the many factors that may influence the effects of prescribed treatment to manage pain in different ethnic groups.
